Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens

被引:114
作者
Tennant, RW
Spalding, J
French, JE
机构
[1] Natl. Inst. of Environ. Hlth. Sci., Lab. of Environ. C., Res. Triangle Park, NC 27709
来源
MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY | 1996年 / 365卷 / 1-3期
关键词
transgenic mouse; bioassay model; carcinogenesis; p53; heterozygote; Tg center dot Ac;
D O I
10.1016/S0165-1110(96)90016-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Data supporting the use of transgenic lines to identify carcinogens and noncarcinogens are thus far based on a limited number of chemicals for which there are also long-term bioassay results in rats and/or mice. Six chemicals have been tested in the heterozygous p53-deficient mice and 13 in the Tg . AC line. The results show that the p53(def) responds rapidly to mutagenic carcinogens and the Tg . AC responds rapidly to both mutagenic and nonmutagenic carcinogens. Neither transgenic line responded to the noncarcinogens that were tested. The p53(def) line failed to respond to two nonmutagenic carcinogens (N-methyloacrylamide and reserpine), the Tg . AC line failed to respond to ethyl acrylate, a nonmutagenic chemical that induced tumors of the forestomach when administered by gavage, and to triethanolamine that caused an increase in hepatocellular tumors in B6C3F1 mice via skin painting. Both of the latter chemicals are examples of highly specific responses related to either route of administration or to strain susceptibility. Further efforts to evaluate the range of chemicals to which these transgenic lines respond are currently in progress.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 36 条
  • [1] TRANSGENIC MODELS OF TUMOR-DEVELOPMENT
    ADAMS, JM
    CORY, S
    [J]. SCIENCE, 1991, 254 (5035) : 1161 - 1167
  • [2] MOLECULAR THEMES IN ONCOGENESIS
    BISHOP, JM
    [J]. CELL, 1991, 64 (02) : 235 - 248
  • [3] CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3
  • [4] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [5] DRINKWATER NR, 1994, NONGENOTOXIC CARCINO, P219
  • [6] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093
  • [7] FOCAL TRANSGENE EXPRESSION ASSOCIATED WITH PAPILLOMA DEVELOPMENT IN V-HA-RAS-TRANSGENIC TG.AC MICE
    HANSEN, LA
    TENNANT, R
    [J]. MOLECULAR CARCINOGENESIS, 1994, 9 (03) : 143 - 154
  • [8] DEFECTS IN A CELL-CYCLE CHECKPOINT MAY BE RESPONSIBLE FOR THE GENOMIC INSTABILITY OF CANCER-CELLS
    HARTWELL, L
    [J]. CELL, 1992, 71 (04) : 543 - 546
  • [9] SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE
    HARVEY, M
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    DONEHOWER, LA
    [J]. NATURE GENETICS, 1993, 5 (03) : 225 - 229
  • [10] GENETIC BACKGROUND ALTERS THE SPECTRUM OF TUMORS THAT DEVELOP IN P53-DEFICIENT MICE
    HARVEY, M
    MCARTHUR, MJ
    MONTGOMERY, CA
    BRADLEY, A
    DONEHOWER, LA
    [J]. FASEB JOURNAL, 1993, 7 (10) : 938 - 943